GlassScriptPhysician profile
Richard A Shugoll
NPI 1063454049
$3,254.77
in general payments reported to CMS, 2019-2025
22 companies · $902 in 2025
The $902 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $23.69 · 2021: $28.86 · 2022: $367 · 2023: $658 · 2024: $1,002 · 2025: $902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,561.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $512.03 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $439.38 | 2019-2024 | Xarelto |
| Stryker Corporation | $401.51 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Verge Medical, INC. | $324.91 | 2024 | |
| Medtronic, INC. | $303.46 | 2022-2024 | Onyx Frontier, Ffrangio, Cobalt Dr Mri Surescan |
| Novartis Pharmaceuticals Corporation | $230.21 | 2021-2025 | |
| Inari Medical, INC. | $151.55 | 2022 | |
| Teleflex LLC | $147.81 | 2023 | Guideliner |
| Abbott Laboratories | $132.89 | 2023-2024 | Esprit, Aveir |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $101.91 | 2019-2024 | Lifevest |
| Sanofi-Aventis U.S. LLC | $91.19 | 2019 | |
| Shockwave Medical, INC | $86.83 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $82.32 | 2022-2025 | Avvigo Guidance System, Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.98 | 2020-2024 | Jardiance |
| Janssen Scientific Affairs, LLC | $36.09 | 2023 | Xarelto |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $32.56 | 2022-2024 | Eliquis |
| Kiniksa Pharmaceuticals International, Plc | $26.37 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $20.05 | 2025 | Optowire |
| Imperative Care, INC | $16.79 | 2025 | Symphony Catheter |
| Medtronic USA, INC. | $15.59 | 2019 | |
| Livanova USA, INC. | $15.50 | 2019 | |
| Pfizer INC. | $13.84 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Shugoll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.